---
title: Multicenter Longitudinal Quality Assessment of MS-Based Proteomics in Plasma
  and Serum
date: '2025-02-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39918541/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250207170839&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Advancing MS-based proteomics toward clinical applications evolves around
  developing standardized start-to-finish and fit-for-purpose workflows for clinical
  specimens. Steps along the method design involve the determination and optimization
  of several bioanalytical parameters such as selectivity, sensitivity, accuracy,
  and precision. In a joint effort, eight proteomics laboratories belonging to the
  MSCoreSys initiative including the CLINSPECT-M, MSTARS, DIASyM, and SMART-CARE consortia
  ...
disable_comments: true
---
Advancing MS-based proteomics toward clinical applications evolves around developing standardized start-to-finish and fit-for-purpose workflows for clinical specimens. Steps along the method design involve the determination and optimization of several bioanalytical parameters such as selectivity, sensitivity, accuracy, and precision. In a joint effort, eight proteomics laboratories belonging to the MSCoreSys initiative including the CLINSPECT-M, MSTARS, DIASyM, and SMART-CARE consortia ...